Spero Therapeutics Inc
Biotechnology
Healthcare
SPRO
55.38 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
2.00
52 week high
3.04
high
2.05
52 week low
0.00
previous Close
2.03
P/E ratio
market cap
163 M
div yield
0
net profit margin
0.00 %
250.00 %
operating incoming
0.00 %
net change in cash
0.00 %
top